Literature DB >> 23934715

Genetic heterogeneity and risk of acute respiratory distress syndrome.

Nuala J Meyer1, Jason D Christie.   

Abstract

Genetic variation explains some of the observed heterogeneity in patients' risk for developing the acute respiratory distress syndrome (ARDS). Although the lack of extant family pedigrees for ARDS precludes an estimate of heritability of the syndrome, ARDS may function as a pattern of response to injury or infection, traits that exhibit strong heritability. A total of 34 genes have now been reported to influence ARDS susceptibility, the majority of which arose as candidate genes based on the current pathophysiological understanding of ARDS, with particular focus on inflammation and endothelial or epithelial injury. In addition, novel candidate genes have emerged from agnostic genetic approaches, including genome-wide association studies, orthologous gene expression profiling across animal models of lung injury, and human peripheral blood gene expression data. The genetic risk for ARDS seems to vary both by ancestry and by the subtype of ARDS, suggesting that both factors may be valid considerations in clinical trial design. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2013        PMID: 23934715     DOI: 10.1055/s-0033-1351121

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  22 in total

1.  NF-κB inhibitors impair lung epithelial tight junctions in the absence of inflammation.

Authors:  Christina Ward; Barbara Schlingmann; Arlene A Stecenko; David M Guidot; Michael Koval
Journal:  Tissue Barriers       Date:  2015-04-03

Review 2.  [Ventilation as a trigger for organ dysfunction and sepsis].

Authors:  J Karsten; H Heinze
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-05-14       Impact factor: 0.840

Review 3.  Fifty Years of Research in ARDS. Genomic Contributions and Opportunities.

Authors:  John P Reilly; Jason D Christie; Nuala J Meyer
Journal:  Am J Respir Crit Care Med       Date:  2017-11-01       Impact factor: 21.405

Review 4.  Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise.

Authors:  M Isabel García-Laorden; José A Lorente; Carlos Flores; Arthur S Slutsky; Jesús Villar
Journal:  Ann Transl Med       Date:  2017-07

Review 5.  Definition and epidemiology of acute respiratory distress syndrome.

Authors:  Emanuele Rezoagli; Roberto Fumagalli; Giacomo Bellani
Journal:  Ann Transl Med       Date:  2017-07

6.  Haptoglobin-2 variant increases susceptibility to acute respiratory distress syndrome during sepsis.

Authors:  V Eric Kerchberger; Julie A Bastarache; Ciara M Shaver; Hiromasa Nagata; J Brennan McNeil; Stuart R Landstreet; Nathan D Putz; Wen-Kuang Yu; Jordan Jesse; Nancy E Wickersham; Tatiana N Sidorova; David R Janz; Chirag R Parikh; Edward D Siew; Lorraine B Ware
Journal:  JCI Insight       Date:  2019-11-01

Review 7.  Beyond single-nucleotide polymorphisms: genetics, genomics, and other 'omic approaches to acute respiratory distress syndrome.

Authors:  Nuala J Meyer
Journal:  Clin Chest Med       Date:  2014-09-23       Impact factor: 2.878

Review 8.  Acute Respiratory Distress Syndrome Phenotypes.

Authors:  John P Reilly; Carolyn S Calfee; Jason D Christie
Journal:  Semin Respir Crit Care Med       Date:  2019-05-06       Impact factor: 3.119

9.  IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist.

Authors:  Nuala J Meyer; Rui Feng; Mingyao Li; Yang Zhao; Chau-Chyun Sheu; Paula Tejera; Robert Gallop; Scarlett Bellamy; Melanie Rushefski; Paul N Lanken; Richard Aplenc; Grant E O'Keefe; Mark M Wurfel; David C Christiani; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2013-05-01       Impact factor: 21.405

Review 10.  Endothelial cell signaling and ventilator-induced lung injury: molecular mechanisms, genomic analyses, and therapeutic targets.

Authors:  Ting Wang; Christine Gross; Ankit A Desai; Evgeny Zemskov; Xiaomin Wu; Alexander N Garcia; Jeffrey R Jacobson; Jason X-J Yuan; Joe G N Garcia; Stephen M Black
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-12-15       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.